Comments
Loading...

Plus Therapeutics Stock Price, Quotes and Forecasts

PSTVNASDAQ
Logo brought to you by Benzinga Data
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Plus Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:PSTV | Benzinga

Explore Plus Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PSTV.

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
2
Nov 24
1
Dec 24
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
Open$0.71
Close-
Volume / Avg.1.63M / 8.39M
Day Range$0.56 - $0.71
52 Wk Range0.24 - 2.67
Market Cap$3.44M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
40
Short Interest
2.43%
Days to Cover1
About Plus Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, develo...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PSTV
ALZN

FAQ

Q

How do I buy Plus Therapeutics (PSTV) stock?

A

You can purchase shares of Plus Therapeutics (NASDAQ:PSTV) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Plus Therapeutics (PSTV) competitors?

Q

What is the forecast, or price target, for Plus Therapeutics (PSTV) stock?

A

Plus Therapeutics has a consensus price target of $10.60.

Q

What is the current price for Plus Therapeutics (PSTV)?

A

The stock price for Plus Therapeutics (NASDAQ: PSTV) is $0.5831 last updated March 17, 2025 at 1:28 PM EDT.

Q

Does Plus Therapeutics (PSTV) pay a dividend?

A

There are no upcoming dividends for Plus Therapeutics.

Q

When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?

A

Plus Therapeutics’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Q

Is Plus Therapeutics (PSTV) going to split?

A

There is no upcoming split for Plus Therapeutics.

Q

What sector and industry does Plus Therapeutics (PSTV) operate in?

A

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch